RADICAL CYSTECTOMY FOR HISTORICAL AND PATHOLOGIC-T1, N0, M0 (STAGE-A) TRANSITIONAL CELL-CANCER - NEED FOR ADJUVANT SYSTEMIC CHEMOTHERAPY

被引：24
作者：
SIREF, LE [1 ]
ZINCKE, H [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT UROL,ROCHESTER,MN 55905
来源：
UROLOGY | 1988年 / 31卷 / 04期
关键词：
D O I：
10.1016/0090-4295(88)90087-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 311
页数：3
相关论文
共 50 条
[11]   Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: Therapeutic results and voice preservation [J].
Spector, JG ;
Sessions, DG ;
Chao, KSC ;
Haughey, BH ;
Hanson, JM ;
Simpson, JR ;
Perez, CA .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1999, 21 (08) :707-717
[12]   IMPACT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH T1N1M0/T2N0M0 GASTRIC CANCER [J].
Chen, Yi Fu ;
Le, Puo-Hsien ;
Chen, Tsung Hsing ;
Kuo, Chia Jung ;
Wang, Shang Yu ;
Chou, Wen Chi ;
Yeh, Ta Sen ;
Hsu, Jun Te .
GASTROENTEROLOGY, 2024, 166 (05) :S669-S669
[13]   Evaluation of Clinical Prognostic Factors in T1 N0 M0 Head and Neck Basal Cell Carcinoma [J].
Morselli, Paolo ;
Zollino, Ilaria ;
Pinto, Valentina ;
Brunelli, Giorgio ;
Carinci, Francesco .
JOURNAL OF CRANIOFACIAL SURGERY, 2009, 20 (01) :98-100
[14]   Radikale Zystektomie vs. Radiochemotherapie zur Behandlung des Blasenkarzinoms im Stadium T2–4a N0 M0Radical cystectomy vs. chemoradiation for the treatment of T2–4a N0 M0 bladder cancer [J].
Gunther Klautke .
Strahlentherapie und Onkologie, 2016, 192 (11) :823-824
[15]   Factors Affecting Outcomes of Limited-Stage I, IIA (T1-T2, N0, M0) Small Cell Lung Cancer: An Analysis of the National Cancer Database [J].
Abdullah, H. M. ;
Das, A. C. ;
Abughanimeh, O. K. ;
Muir, K. -L. ;
Sharma, B. B. ;
Marr, A. S. ;
Smith, L. M. ;
Ganti, A. K. .
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :S677-S677
[16]   Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer [J].
Kodama, Ken ;
Higashiyama, Masahiko ;
Okami, Jiro ;
Tokunaga, Toshiteru ;
Imamura, Fumio ;
Nakayama, Tomio ;
Inoue, Atsuo ;
Kuriyama, Keiko .
ANNALS OF THORACIC SURGERY, 2016, 101 (02) :504-511
[17]   Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer [J].
Jeon, Chul-Hyo ;
Kim, Min Ki ;
Lee, In Kyu .
ANNALS OF COLOPROCTOLOGY, 2019, 35 (05) :254-261
[18]   Should patients with a complete response (CR) to chemotherapy for stage T4b, M0, bladder cancer be advised immediate radical cystectomy? [J].
Geertsen, P ;
Steven, K ;
Poulsen, AL ;
Sengelov, L .
JOURNAL OF UROLOGY, 2002, 167 (04) :285-285
[19]   THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER [J].
FERGUSON, MK ;
LITTLE, AG ;
GOLOMB, HM ;
HOFFMAN, PC ;
DEMEESTER, TR ;
BEVERIDGE, R ;
SKINNER, DB .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03) :344-349
[20]   Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: Prognostic factor analysis [J].
Splinter, TAW ;
PavoneMacaluso, M ;
Jacqmin, D ;
Roberts, JT ;
Carpentier, P ;
dePauw, M ;
Sahmoud, T .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) :1129-1134
12345